Followers | 897 |
Posts | 149146 |
Boards Moderated | 0 |
Alias Born | 08/13/2010 |
![](https://investorshub.advfn.com/uicon/213855.png?cb=1701432176)
Friday, June 05, 2020 1:09:37 PM
Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.
Recent GLPG News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/23/2024 08:10:04 PM
- Form SC 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 08/23/2024 08:01:26 PM
- Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma • GlobeNewswire Inc. • 08/23/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/21/2024 08:10:04 PM
- Galapagos receives transparency notification from FMR LLC • GlobeNewswire Inc. • 08/20/2024 08:01:00 PM
- Galapagos reports half-year 2024 financial results and provides second quarter business update • GlobeNewswire Inc. • 08/01/2024 08:01:00 PM
- BridGene Biosciences Expands Strategic Collaboration with Galapagos to Develop Selective Oral SMARCA2 PROTAC in Precision Oncology • PR Newswire (US) • 08/01/2024 08:01:00 PM
- Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024 • GlobeNewswire Inc. • 06/14/2024 08:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/30/2024 08:44:37 PM
- Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future solid tumor indications • GlobeNewswire Inc. • 05/30/2024 08:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/16/2024 08:28:26 PM
- Galapagos creates new subscription right plans • GlobeNewswire Inc. • 05/16/2024 08:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/16/2024 12:11:10 PM
- Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S. • GlobeNewswire Inc. • 05/15/2024 08:01:00 PM
- Galapagos reports first quarter 2024 financial results • GlobeNewswire Inc. • 05/02/2024 08:01:00 PM
- Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024 • GlobeNewswire Inc. • 04/30/2024 08:01:00 PM
- Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024 • GlobeNewswire Inc. • 04/04/2024 08:01:00 PM
- Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings • GlobeNewswire Inc. • 03/28/2024 08:01:00 PM
- Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board • GlobeNewswire Inc. • 03/26/2024 08:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/23/2024 11:41:59 AM
- Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline • GlobeNewswire Inc. • 02/22/2024 09:01:00 PM
- Galapagos announces full year 2023 results and outlook for 2024 • GlobeNewswire Inc. • 02/22/2024 09:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/16/2024 11:00:09 AM
- Galapagos presents at EBMT-EHA annual meeting 2024 • GlobeNewswire Inc. • 02/15/2024 09:01:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 10:41:32 PM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM